Summary:
Researchers at the University of Colorado Anschutz have discovered how herpes simplex virus type 1 (HSV-1), the virus commonly responsible for cold sores, reprograms the brain’s resident immune cells. After infection, microglia shift into an interferon-driven antiviral state while reducing the expression of genes needed for routine maintenance and support of neural tissue. These chromatin-level changes mirror immune patterns observed in Alzheimer’s disease, suggesting that repeated or chronic exposure to common viral pathogens could prime the brain for neurodegeneration.
Key Facts:
- Cellular Reprogramming: HSV-1 infection pushes microglia to prioritize strong interferon antiviral signaling at the cost of their normal roles in synaptic pruning, debris clearance, and metabolic support.
- Chromatin Remodeling: The virus remodels chromatin accessibility in microglia, locking in gene expression changes that shape long-term immune behavior rather than producing only a transient inflammatory response.
- Link to Alzheimer’s-Related Signatures: The microglial state induced by HSV-1 resembles molecular profiles associated with aging and genetic risk factors for Alzheimer’s disease, providing a plausible mechanistic connection between viral exposure and neurodegenerative vulnerability.
Source: University of Colorado Anschutz Medical Campus
Herpes simplex virus type 1 (HSV-1) infects sensory neurons and is present lifelong in a large portion of adults worldwide. While it often stays dormant in peripheral ganglia, growing clinical and epidemiological evidence links HSV-1 with chronic neuroinflammation and increased risk for late-onset Alzheimer’s disease.
Until now, the cellular and molecular pathways by which a common mucosal virus could alter brain immune function and contribute to neurodegeneration were not well defined.
A team led by neuroscientists at the University of Colorado Anschutz Medical Campus has shown that HSV-1 directly remodels microglia’s transcriptional and epigenetic programs. Published in PLOS Pathogens, the study integrates single-cell and spatial multiomic approaches to reveal that HSV-1 drives sustained changes in microglial behavior, tipping them into a defensive mode that undermines their homeostatic roles.
From Routine Maintenance to Emergency Defense
Microglia are the central nervous system’s caretakers and first responders. Under healthy conditions they survey tissue, remove redundant synapses, clear cellular debris, and help eliminate toxic proteins such as amyloid-beta.
Using high-resolution single-cell profiling, the researchers examined how individual microglia respond to HSV-1 exposure. The virus induced distinct microglial populations dominated by interferon signaling — a powerful antiviral program. This strong, focused immune activation came with a trade-off: genes that support basic homeostatic functions were substantially downregulated, indicating a reallocation of cellular resources toward defense.
“Microglia serve both as the brain’s security system and its maintenance crew,” said Christy Niemeyer, PhD, assistant professor of neurology at CU Anschutz and senior author of the study. “When HSV-1 is present, they switch into emergency mode. That state may help clear infection but can reduce their capacity for routine maintenance even after the acute phase resolves.”
Chromatin Remodeling Creates Local Vulnerability
These immune shifts were not uniform across the brain but occurred in discrete regions where viral antigen was found, creating localized pockets of heightened immune activation. Epigenetic profiling revealed that HSV-1 exposure changes chromatin accessibility in microglia, altering which genes are available for transcription and effectively reprogramming cellular identity and response potential.
“The virus is not merely causing transient inflammation,” Niemeyer explained. “It’s reorganizing the molecular programs that determine microglial behavior. A critical question is whether this reprogramming persists and contributes to long-term vulnerability.”
Shared Immune Features with Neurodegeneration
The microglial states induced by HSV-1 strongly resembled profiles documented in aging and neurodegenerative disease models. Key transcriptional regulators amplified in infected microglia — including STAT1/2, IRF1, and CEBPB — are also implicated in immune responses connected to Alzheimer’s risk.
“While this study does not prove HSV-1 causes Alzheimer’s, it highlights a shared immune programming axis linking infection, aging, and genetic susceptibility,” said Kimberley Bruce, PhD, associate professor of medicine at CU Anschutz and co-senior author. The results support a model in which repeated viral reactivations over a lifetime could progressively diminish microglial homeostatic capacity, making neural circuits more susceptible to toxic protein accumulation and dysfunction.
Identifying how common viruses reshape the brain’s immune environment may clarify why some individuals are more prone to neurodegeneration and point to potential strategies for preserving microglial health.
The research team is planning follow-up studies to determine the permanence of these chromatin changes and to assess how intermittent HSV-1 reactivation across decades affects cognitive resilience and long-term neurological health.
Editorial Notes:
- Article edited by a Neuroscience News editor.
- Journal paper reviewed in full by the reporting team.
- Additional explanatory context provided by staff.
About this Alzheimer’s Disease Research:
- Media Contact: David Kelly
- Source: University of Colorado Anschutz Medical Campus
- Image Credit: Image credited to Neuroscience News
- Original Research (Open Access): PLOS Pathogens (Oct 1, 2026). Title: “Intranasal HSV‑1 infection drives region‑specific interferon‑dominant microglial remodeling.” Authors: Seth Frietze, Cameron Lunn, Dean Oldham, Joseph R. Boyd, Andrew N. Bubak, Amalia Bustillos Saucedo, Maria A. Nagel, Diego Restrepo, Kimberley D. Bruce, and Christy S. Niemeyer.
- DOI: 10.1371/journal.ppat.1014684
Abstract
Herpes simplex virus type 1 (HSV-1) is a neurotropic pathogen able to invade the central nervous system and is associated with chronic neuroinflammation, cognitive decline, and neurodegenerative disease. Microglia coordinate the initial immune response to HSV‑1, but the molecular mechanisms that sustain their neuroinflammatory activity in vivo have been unclear.
To define transcriptional and epigenetic mechanisms shaping microglial responses during acute HSV‑1 infection in vivo, the investigators combined single‑nucleus RNA sequencing, chromatin accessibility profiling, and spatial proteomic and transcriptomic mapping in an intranasal infection model.
Single‑cell multiome analysis of CD11b⁺ nuclei detected transcriptionally and epigenetically distinct microglial and macrophage populations. HSV‑1 infection shifted monocyte-lineage states toward an overrepresentation of interferon-responsive microglia and macrophage-associated populations, marked by amplification of Stat1/2, Irf1, and Cebpb rather than uniform inflammatory activation. Concurrently, homeostatic microglial gene signatures (for example, ApoE and Cst3) were reduced after infection.
Spatial transcriptomics localized HSV‑1 antigen to target brainstem regions enriched for predicted STAT1/2, IRF1, and CEBPB-regulated transcriptional programs identified by single‑nucleus analysis, showing that these inferred regulatory networks operate within anatomically defined sites in vivo. Complementary spatial proteomics confirmed increased microglial activation and astrocytic responses specifically within HSV‑1 antigen-positive regions.
Together, these integrated multiomic data demonstrate that HSV‑1 induces localized transcriptional and epigenetic remodeling of microglia dominated by interferon-driven regulatory programs and loss of homeostatic signatures. By linking single‑cell regulatory architecture to spatially restricted tissue responses, the findings offer a mechanistic explanation for how localized viral infection can sustain neuroinflammation and contribute to long-term neurological vulnerability and increased risk of neurodegenerative disease.